Get the latest tech news
NewLimit, founded by Coinbase CEO Brian Armstrong, raises $130M to develop age-reversing treatments
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised $130M.
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick Collison, and others. In the meantime, the company wants to continue developing new anti-aging medicine using an AI model and then testing the most promising of these machine-generated drugs in its laboratory.
Or read this on TechCrunch
